SANUWAVE Health Statistics Share Statistics SANUWAVE Health has 8.57M
shares outstanding. The number of shares has increased by -99.28%
in one year.
Shares Outstanding 8.57M Shares Change (YoY) -99.28% Shares Change (QoQ) 0.08% Owned by Institutions (%) 29.27% Shares Floating 8.04M Failed to Deliver (FTD) Shares 17,741 FTD / Avg. Volume 21.06%
Short Selling Information The latest short interest is 467.69K, so 5.46% of the outstanding
shares have been sold short.
Short Interest 467.69K Short % of Shares Out 5.46% Short % of Float 8.69% Short Ratio (days to cover) 9.86
Valuation Ratios The PE ratio is -3.27 and the forward
PE ratio is 47.98.
SANUWAVE Health's PEG ratio is
0.08.
PE Ratio -3.27 Forward PE 47.98 PS Ratio 3.15 Forward PS 6 PB Ratio -8.07 P/FCF Ratio 52.24 PEG Ratio 0.08
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for SANUWAVE Health.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.43,
with a Debt / Equity ratio of -2.
Current Ratio 0.43 Quick Ratio 0.34 Debt / Equity -2 Debt / EBITDA -1.54 Debt / FCF 12.98 Interest Coverage 0.4
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $709.43K Profits Per Employee $-682K Employee Count 46 Asset Turnover 1.08 Inventory Turnover 1.95
Taxes Income Tax 27K Effective Tax Rate -0.09%
Stock Price Statistics The stock price has increased by 606.44% in the
last 52 weeks. The beta is 1.29, so SANUWAVE Health's
price volatility has been higher than the market average.
Beta 1.29 52-Week Price Change 606.44% 50-Day Moving Average 35.64 200-Day Moving Average 29.23 Relative Strength Index (RSI) 65.29 Average Volume (20 Days) 84,230
Income Statement In the last 12 months, SANUWAVE Health had revenue of 32.63M
and earned -31.37M
in profits. Earnings per share was -7.03.
Revenue 32.63M Gross Profit 24.55M Operating Income 5.42M Net Income -31.37M EBITDA -16.56M EBIT -17.71M Earnings Per Share (EPS) -7.03
Full Income Statement Balance Sheet The company has 10.24M in cash and 25.5M in
debt, giving a net cash position of -15.26M.
Cash & Cash Equivalents 10.24M Total Debt 25.5M Net Cash -15.26M Retained Earnings -251.42M Total Assets 33.05M Working Capital -26.33M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 2.46M
and capital expenditures -490K, giving a free cash flow of 1.97M.
Operating Cash Flow 2.46M Capital Expenditures -490K Free Cash Flow 1.97M FCF Per Share 0.44
Full Cash Flow Statement Margins Gross margin is 75.23%, with operating and profit margins of 16.6% and -96.13%.
Gross Margin 75.23% Operating Margin 16.6% Pretax Margin -96.05% Profit Margin -96.13% EBITDA Margin -50.75% EBIT Margin 16.6% FCF Margin 6.02%
Dividends & Yields SNWV does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for SNWV is $55,
which is 22.2% higher than the current price. The consensus rating is "Strong Buy".
Price Target $55 Price Target Difference 22.2% Analyst Consensus Strong Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 18, 2024. It was a
backward
split with a ratio of 1:375.
Last Split Date Oct 18, 2024 Split Type backward Split Ratio 1:375
Scores Altman Z-Score -8.33 Piotroski F-Score 5
